王瀚之 Email & Phone Number

Hanzhi has long focused his practice on the overseas listing and capital market fundraising activities of PRC companies. Key representations included: • XPeng Inc. (09868-W.HK/XPEV.NYSE) on its US$1,807 million Global Offering comprising of Hong Kong Public Offering and SEC registered follow-on offering, and HKSE dual primary listing.• Bookrunners in the proposed SEC registered follow-on offering of a reputable electric vehicle manufacturer under its general mandate.• Morgan Stanley and Haitong International on the HKSE listing of Gaush Medical Ltd, as drafting counsel.• Goldman Sachs and UBS, as the Joint Sponsors, and the Underwriters on the US$263 million Global Offering and HKSE listing of New Horizon Health Limited (06606.HK).• Goldman Sachs, CLSA and Bank of America, as the Joint Sponsors, and the Underwriters on the US$404 million Global Offering and HKSE listing of Kangji Medical Holding Co., Ltd. (09997.HK).• China Tobacco International (HK) (06055.HK) on its US$100 million Global Offering and HKSE listing.• Citigroup, Credit Suisse, Morgan Stanley, J.P. Morgan and CICC on the US$5 billion SEC registered senior unsecured notes offering of Alibaba Group Holding Limited (BABA.NYSE/09988.HK). • Postal Savings Bank of China Co., Ltd. (01658.HK) on its US$7.4 billion Global Offering and HKSE listing, and its US$7.3 billion AT1 preference shares placement.• CICC, Credit Suisse and the Underwriters on the HKSE listing and US$297 million Global Offering of AAG Energy Holdings Limited (02686.HK).Hanzhi also participated in a series of M&A transactions and Pre IPO investments.